Search

Search results

764 results found

Reply: Safety of Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal in Critically Ill Patients With Primary Neurological Injuries.

Publication: Journal Article

Deveau, Robert, Adrian Wong, Ifeoma Mary Eche, Tuyen Yankama, and Corey R Fehnel. 2025. “Reply: Safety of Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal in Critically Ill Patients With Primary Neurological Injuries.”. The Annals of Pharmacotherapy, 10600280251389143.

Mitochondrial control of glycerolipid synthesis by a PEP shuttle

Publication: Journal Article

Yamamuro, Tadashi, Daisuke Katoh, Guilherme Martins Silva, Hiroshi Nishida, Satoshi Oikawa, Yusuke Higuchi, Dandan Wang, et al. 2026. “Mitochondrial Control of Glycerolipid Synthesis by a PEP Shuttle”. Cell.

New publication in Cell!

News: March 19, 2026

Our work in collaboration with Kajimura's lab is published in Cell! Congratulations to all authors. Please check it out: Tadashi Yamamuro, Daisuke Katoh, Guilherme Martins Silva, Hiroshi Nishida, Satoshi Oikawa, Yusuke Higuchi, Dandan Wang, Masanori Fujimoto, Naofumi Yoshida, Mark Li, Jihoon Shin...

Impact of Hospital Teaching Status on Atrial Fibrillation Ablation Procedural Approaches and Complications: Insights From the National Cardiovascular Data Registry.

Publication: Journal Article

Beyer, Sebastian E, Jason Nelson, Yang Song, Daniel Kramer, Bruce B Lerman, Christian Sohns, Philipp Sommer, and Jim W Cheung. 2025. “Impact of Hospital Teaching Status on Atrial Fibrillation Ablation Procedural Approaches and Complications: Insights From the National Cardiovascular Data Registry.”. Journal of the American Heart Association 14 (24): e044436.

Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.

Publication: Journal Article

Pinkerton, JoAnn, V, James A Simon, Hadine Joffe, Pauline M Maki, Rossella E Nappi, Nick Panay, Claudio N Soares, et al. 2024. “Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.”. JAMA 332 (16): 1343-54.

Promoting good mental health over the menopause transition.

Publication: Journal Article

Brown, Lydia, Myra S Hunter, Rong Chen, Carolyn J Crandall, Jennifer L Gordon, Gita D Mishra, Viktoria Rother, Hadine Joffe, and Martha Hickey. 2024. “Promoting Good Mental Health over the Menopause Transition.”. Lancet (London, England) 403 (10430): 969-83.

A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis.

Publication: Journal Article

Refardt, Julie, Cornelia Imber, Clara O Sailer, Nica Jeanloz, Laura Potasso, Alexander Kutz, Andrea Widmer, et al. 2020. “A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients With the Syndrome of Inappropriate Antidiuresis.”. Journal of the American Society of Nephrology : JASN 31 (3): 615-24.

Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis.

Publication: Journal Article

Sailer, Clara Odilia, Odile Gaisl, Svetlana Beglinger, Martina Frech-Dörfler, Vivienne Sommer, Maya Horst Lüthy, and Mirjam Christ-Crain. 2023. “Copeptin Improves Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis.”. European Journal of Endocrinology 188 (3).

Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome.

Publication: Journal Article

Sailer, Clara Odilia, Julie Refardt, Claudine Angela Blum, Ingeborg Schnyder, Jose Alberto Molina-Tijeras, Wiebke Fenske, and Mirjam Christ-Crain. 2021. “Validity of Different Copeptin Assays in the Differential Diagnosis of the Polyuria-Polydipsia Syndrome.”. Scientific Reports 11 (1): 10104.

Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.

Publication: Journal Article

Atila, Cihan, Clara O Sailer, Stefano Bassetti, Sarah Tschudin-Sutter, Roland Bingisser, Martin Siegemund, Stefan Osswald, et al. 2021. “Prevalence and Outcome of Dysnatremia in Patients With COVID-19 Compared to Controls.”. European Journal of Endocrinology 184 (3): 409-18.